Drug Trial Radar · NCT07116746
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
Last checked: Nov 19, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Dec 3, 2025
Primary completion
Nov 2026
Study completion Feb 2027
Sponsor
- Lead sponsor
- Arthrosi TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase treatment (eg., pegloticase). Failed uricase treatment is defined as having an inherent intolerance, anaphylaxis, infusion reaction, antibody development, and/or at least one sUA level that rose to greater than 6 mg/dL while on therapy.
Conditions
- Gout
- Gouty Arthritis
- Hyperuricemia
- Gout Chronic
- Refractory Gout
- Uncontrolled Gout
- Tophaceous Gout
Interventions
AR882 75 mgDrug
Solid Oral Capsule
XOI Low DoseDrug
Solid Oral Tablet
XOI High DoseDrug
Solid Oral Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum urate (uric acid) (sUA) level < 6 mg/dL at month 6Time frame: 24 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Arthrosi Investigative Site (105)
Margate, Florida
Arthrosi Investigative Site (102)
Miami, Florida
Arthrosi Investigative Site (109)
Tampa, Florida
Arthrosi Investigative Site (106)
Jackson, Mississippi
Arthrosi Investigative Site (108)
Charlotte, North Carolina
Arthrosi Investigative Site (103)
Duncansville, Pennsylvania
Arthrosi Investigative Site (104)
West Lake Hills, Texas
Arthrosi Investigative Site (107)
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.